A14UQC

Abivax SA · LS:A14UQC

75.95 EUR−2.65 −3.37%

Abivax SA (LS:A14UQC) last traded at 75.95 EUR, down 3.37% on the day. Over the past year the stock is down 17.62%. Its 52-week range is 60.90 to 148.00. It is in the Health Technology sector (Pharmaceuticals: Other).

Key statistics

Open77.50

Day range75.95 – 77.85

52-week range60.90 – 148.00

Volume790

Average volume (10 days)691

Market cap (USD)7.45 B

EPS (TTM) (USD)−5.98

Dividend yield0.00%

Beta (1 year)1.66

Revenue (TTM) (USD)0

Employees69

Performance

−2.75%1 week

−9.37%1 month

−30.13%3 months

−29.61%6 months

−35.85%Year to date

−17.62%1 year

Technical reading

Strongly bearish

Daily summary of what 11 oscillators and 15 moving averages show. See every indicator

Latest headlines

Abivax to Participate in Upcoming Fall Investor ConferencesEQS · 02 Nov 2026
Abivax to Participate in Upcoming Fall Investor ConferencesGlobeNewswire · 02 Nov 2026
Abivax Price Target Cut to $96.00/Share From $118.00 by WedbushDow Jones Newswires · 21 Oct 2026
Abivax Price Target Maintained With a $175.00/Share by GuggenheimDow Jones Newswires · 20 Oct 2026
Cedar Grove Capital Q3: Adds Zedcor, Auxly; exits MTY, ClearPointSeeking Alpha · 15 Oct 2026
Seeking Alpha’s Quant Spotlight: Highest and lowest rated healthcare stocks ahead of Q3Seeking Alpha · 13 Oct 2026
Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026EQS · 30 Sep 2026
Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026GlobeNewswire · 30 Sep 2026

Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.